The EU’s HTA regulation: Are we ready for kick-off?

On Tuesday 8 October from 15:00-17:30 CEST, the 2024 ECO Community 365 Roundtable series will continue with a spotlight placed on the issue of ‘EU HTA Cooperation’.

 

A landmark piece of European Union legislation to achieve greater cooperation between countries on Health Technology Assessment (HTA) is due to come into force in January 2025, with cancer medicines among the first group of therapies in its focus. Is the EU ready for Joint Clinical Assessments? Have stakeholder views been taken account of? Is there still time to address any remaining concerns? Register and participate in the roundtable to be a part of the conversation.

 

The Roundtable will be co-chaired by Giuseppe Curigliano, President, European Society of Breast Cancer Specialists; and Natacha Bolaños, Regional Manager for Europe, Lymphoma Coalition. 

08 October 2024 15:00 - 17:30 CEST

Virtual

 Apply for Registration

community 365 roundtable eu hta cooperation visual 1

Programme

15:00-15:20 Welcome and introductions 

15:20-16:00 Session 1, EU level HTA decisions – Who decides and how?

16:00-16:40 Session 2, How will data be used to support EU level HTA decision-making?

16:40-17:2: Session 3, Are countries ready for implementing the EU HTA regulation?

17:20-17:30 Closing remarks and summary

 

More information will be published here soon.

 

Speakers

  • Giuseppe Curigliano ECO Board Member, President, European Society of Breast Cancer Specialists
  • Natacha Bolaños ECO Patient Advisory Committee Member, Regional Manager for Europe, Lymphoma Coalition
  • Tamara Hussong Milagre President and Founder of the EVITA Association - Hereditary Cancer

Speakers

  • Giuseppe Curigliano ECO Board Member, President, European Society of Breast Cancer Specialists
  • Natacha Bolaños ECO Patient Advisory Committee Member, Regional Manager for Europe, Lymphoma Coalition
  • Tamara Hussong Milagre President and Founder of the EVITA Association - Hereditary Cancer
  • Giuseppe Curigliano ECO Board Member, President, European Society of Breast Cancer Specialists
  • Natacha Bolaños ECO Patient Advisory Committee Member, Regional Manager for Europe, Lymphoma Coalition
  • Tamara Hussong Milagre President and Founder of the EVITA Association - Hereditary Cancer

Speakers

  • Giuseppe Curigliano ECO Board Member, President, European Society of Breast Cancer Specialists
  • Natacha Bolaños ECO Patient Advisory Committee Member, Regional Manager for Europe, Lymphoma Coalition
  • Tamara Hussong Milagre President and Founder of the EVITA Association - Hereditary Cancer

Speakers

  • Giuseppe Curigliano ECO Board Member, President, European Society of Breast Cancer Specialists
  • Natacha Bolaños ECO Patient Advisory Committee Member, Regional Manager for Europe, Lymphoma Coalition
  • Tamara Hussong Milagre President and Founder of the EVITA Association - Hereditary Cancer